The global Pen Needles Market is experiencing robust growth due to the increasing prevalence of diabetes and the rising adoption of insulin pens for self-administration. Pen needles are medical devices designed to deliver insulin or other injectable medications conveniently and safely. They offer advantages such as reduced injection pain, precision dosing, and enhanced comfort compared to traditional syringes. In recent years, technological advancements in pen needle design—such as ultra-thin, safety-engineered, and ergonomic models—have significantly improved user experience and adherence to treatment protocols. The growing geriatric population, coupled with increasing awareness about diabetes management and minimally invasive drug delivery, is driving the demand for pen needles across hospitals, clinics, and home healthcare settings worldwide.
One of the key drivers fueling the growth of the Pen Needles Market is the increasing global prevalence of diabetes and other chronic conditions requiring regular injections. With the growing patient population and rising preference for self-administration of insulin, the demand for convenient and less painful injection devices has surged. Additionally, awareness campaigns promoting early diabetes management and the availability of advanced pen needle products with enhanced safety features are boosting market expansion. The increasing shift toward home-based healthcare and self-injection therapies presents a significant opportunity for market players. The growing acceptance of pen needles for personalized and convenient care is fostering innovation in design and functionality. Manufacturers are focusing on producing ultra-thin, painless, and safety-engineered needles to meet patient comfort and compliance needs. Furthermore, the expansion of e-commerce and retail pharmacies is expected to make pen needles more accessible, particularly in emerging economies.
Pen Needles Market, Segmentation
The Pen Needles Market is segmented on the basis of Type, Needle Length, Therapy, Mode of Purchase, and End User.
Type
The Type segment is further classified into Standard Pen Needles and Safety Pen Needles. Among these, the Standard Pen Needles segment accounted for the highest market share in 2023. This dominance is attributed to their cost-effectiveness, widespread availability, and compatibility with most pen injectors. Despite this, safety pen needles are gaining traction due to increasing emphasis on needlestick injury prevention and compliance with healthcare safety regulations.
Needle Length
The Needle Length segment is further classified into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm. Among these, the 4mm pen needles segment accounted for the highest market share in 2023. The popularity of shorter needles is driven by their ability to deliver insulin effectively with minimal discomfort, reducing the risk of intramuscular injection. They are especially preferred by patients requiring multiple daily injections and healthcare professionals promoting comfort and precision.
Some of The Leading/Active Market Players Are:
- Becton, Dickinson and Company (U.S.)
- Novo Nordisk A/S (Denmark)
- Owen Mumford Ltd (U.K.)
- Ypsomed Holding AG (Switzerland)
- Terumo Corporation (Japan)
- HTL-STREFA S.A. (Poland)
- Artsana S.p.A (Italy)
- Allison Medical, Inc. (U.S.)
- Ulticare (U.S.)
- UltiMed, Inc. (U.S.)
- ARKRAY, Inc. (Japan)
- B. Braun Melsungen AG (Germany)
- Smiths Medical (U.K.)
- Nipro Corporation (Japan)
- Hindustan Syringes & Medical Devices Ltd. (India)
and other active players.
Key Industry Developments
-
In April 2024, Becton, Dickinson and Company launched a next-generation safety pen needle designed to enhance patient comfort and reduce needlestick injuries. This innovation integrates ultra-fine needle technology with improved safety mechanisms, supporting healthcare workers’ safety protocols while optimizing insulin delivery efficiency.
- In January 2024, Novo Nordisk A/S partnered with Ypsomed Holding AG to develop eco-friendly pen needles using sustainable materials. This collaboration aims to reduce plastic waste in diabetes care, aligning with global sustainability goals and addressing environmental concerns associated with disposable medical devices.
Key Findings of the Study
• Standard pen needles dominated the market in 2023.
• 4mm needles held the largest share among length categories.
• North America led the global market due to high diabetes prevalence.
• Growing demand for safety pen needles drives innovation.
• Home healthcare adoption opens new growth avenues.
